ID   MINK1_HUMAN             Reviewed;        1332 AA.
AC   Q8N4C8; D3DTK3; D3DTK4; Q5U8Z0; Q9P1X1; Q9P2R8;
DT   28-MAR-2003, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 2.
DT   12-OCT-2022, entry version 193.
DE   RecName: Full=Misshapen-like kinase 1;
DE            EC=2.7.11.1;
DE   AltName: Full=GCK family kinase MiNK;
DE   AltName: Full=MAPK/ERK kinase kinase kinase 6;
DE            Short=MEK kinase kinase 6;
DE            Short=MEKKK 6;
DE   AltName: Full=Misshapen/NIK-related kinase;
DE   AltName: Full=Mitogen-activated protein kinase kinase kinase kinase 6;
GN   Name=MINK1 {ECO:0000312|HGNC:HGNC:17565};
GN   Synonyms=B55, MAP4K6 {ECO:0000250|UniProtKB:Q9JM52}, MINK
GN   {ECO:0000312|EMBL:BAA94838.1}, YSK2, ZC3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000312|EMBL:AAH34673.1};
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=10708748; DOI=10.1016/s0014-5793(00)01247-3;
RA   Dan I., Watanabe N.M., Kobayashi T., Yamashita-Suzuki K., Fukagaya Y.,
RA   Kajikawa E., Kimura W.K., Nakashima T.M., Matsumoto K., Ninomiya-Tsuji J.,
RA   Kusumi A.;
RT   "Molecular cloning of MINK, a novel member of mammalian GCK family kinases,
RT   which is up-regulated during postnatal mouse cerebral development.";
RL   FEBS Lett. 469:19-23(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), FUNCTION, SUBCELLULAR LOCATION,
RP   INTERACTION WITH NCK1, TISSUE SPECIFICITY, ALTERNATIVE SPLICING,
RP   AUTOPHOSPHORYLATION, AND VARIANTS ALA-771 AND LEU-775.
RX   PubMed=15469942; DOI=10.1074/jbc.m404497200;
RA   Hu Y., Leo C., Yu S., Huang B.C., Wang H., Shen M., Luo Y.,
RA   Daniel-Issakani S., Payan D.G., Xu X.;
RT   "Identification and functional characterization of a novel human
RT   misshapen/Nck interacting kinase-related kinase, hMINK beta.";
RL   J. Biol. Chem. 279:54387-54397(2004).
RN   [3]
RP   ERRATUM OF PUBMED:15469942.
RA   Hu Y., Leo C., Yu S., Huang B.C., Wang H., Shen M., Luo Y.,
RA   Daniel-Issakani S., Payan D.G., Xu X.;
RL   J. Biol. Chem. 280:5128-5128(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [5] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANTS ALA-771
RP   AND LEU-775.
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=16337592; DOI=10.1016/j.molcel.2005.10.038;
RA   Nicke B., Bastien J., Khanna S.J., Warne P.H., Cowling V., Cook S.J.,
RA   Peters G., Delpuech O., Schulze A., Berns K., Mullenders J.,
RA   Beijersbergen R.L., Bernards R., Ganesan T.S., Downward J., Hancock D.C.;
RT   "Involvement of MINK, a Ste20 family kinase, in Ras oncogene-induced growth
RT   arrest in human ovarian surface epithelial cells.";
RL   Mol. Cell 20:673-685(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-763, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   FUNCTION, INTERACTION WITH RAP2A, AND SUBCELLULAR LOCATION.
RX   PubMed=18930710; DOI=10.1016/j.bbrc.2008.10.038;
RA   Nonaka H., Takei K., Umikawa M., Oshiro M., Kuninaka K., Bayarjargal M.,
RA   Asato T., Yamashiro Y., Uechi Y., Endo S., Suzuki T., Kariya K.;
RT   "MINK is a Rap2 effector for phosphorylation of the postsynaptic scaffold
RT   protein TANC1.";
RL   Biochem. Biophys. Res. Commun. 377:573-578(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-763, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-763, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641; SER-763 AND SER-782,
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-775, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-763; SER-777; SER-778 AND
RP   SER-782, VARIANT [LARGE SCALE ANALYSIS] LEU-775, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-763, VARIANT [LARGE SCALE
RP   ANALYSIS] LEU-775, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-778, VARIANT [LARGE SCALE
RP   ANALYSIS] LEU-775, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-763, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   FUNCTION.
RX   PubMed=21690388; DOI=10.1073/pnas.1104128108;
RA   Kaneko S., Chen X., Lu P., Yao X., Wright T.G., Rajurkar M., Kariya K.,
RA   Mao J., Ip Y.T., Xu L.;
RT   "Smad inhibition by the Ste20 kinase Misshapen.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:11127-11132(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-763, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641; SER-701; SER-754;
RP   SER-763 AND SER-778, VARIANT [LARGE SCALE ANALYSIS] LEU-775, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-763, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-509, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [23]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-514; ILE-863; VAL-1010 AND VAL-1200.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
RN   [24]
RP   VARIANT [LARGE SCALE ANALYSIS] LEU-775, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
CC   -!- FUNCTION: Serine/threonine kinase which acts as a negative regulator of
CC       Ras-related Rap2-mediated signal transduction to control neuronal
CC       structure and AMPA receptor trafficking. Required for normal synaptic
CC       density, dendrite complexity, as well as surface AMPA receptor
CC       expression in hippocampal neurons. Can activate the JNK and MAPK14/p38
CC       pathways and mediates stimulation of the stress-activated protein
CC       kinase MAPK14/p38 MAPK downstream of the Raf/ERK pathway.
CC       Phosphorylates: TANC1 upon stimulation by RAP2A, MBP and SMAD1. Has an
CC       essential function in negative selection of thymocytes, perhaps by
CC       coupling NCK1 to activation of JNK1.
CC   -!- FUNCTION: Isoform 4 can activate the JNK pathway. Involved in the
CC       regulation of actin cytoskeleton reorganization, cell-matrix adhesion,
CC       cell-cell adhesion and cell migration.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:Q9JM52};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000250|UniProtKB:Q9JM52};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q9JM52};
CC   -!- SUBUNIT: Interacts with TANC1 (By similarity). Interacts with RAP2A.
CC       Isoform 4 interacts with NCK1. {ECO:0000250,
CC       ECO:0000269|PubMed:15469942, ECO:0000269|PubMed:18930710}.
CC   -!- INTERACTION:
CC       Q8N4C8; Q00613: HSF1; NbExp=2; IntAct=EBI-2133481, EBI-719620;
CC       Q8N4C8; O95819: MAP4K4; NbExp=2; IntAct=EBI-2133481, EBI-2511133;
CC       Q8N4C8-4; Q5VY09: IER5; NbExp=2; IntAct=EBI-11475194, EBI-1774000;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15469942,
CC       ECO:0000269|PubMed:18930710}. Postsynaptic density {ECO:0000250}. Cell
CC       projection, axon {ECO:0000250}. Cell projection, dendrite
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Golgi apparatus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=3 {ECO:0000269|PubMed:10708748}; Synonyms=MINK-alpha;
CC         IsoId=Q8N4C8-1; Sequence=Displayed;
CC       Name=1 {ECO:0000269|PubMed:10708748}; Synonyms=MiNK-1, MINK-delta;
CC         IsoId=Q8N4C8-2; Sequence=VSP_007059;
CC       Name=2 {ECO:0000269|PubMed:10708748}; Synonyms=MiNK-2, MINK-gamma;
CC         IsoId=Q8N4C8-3; Sequence=VSP_007059, VSP_007060;
CC       Name=4; Synonyms=MINK-beta;
CC         IsoId=Q8N4C8-4; Sequence=VSP_041871;
CC       Name=5; Synonyms=MINK-eta;
CC         IsoId=Q8N4C8-5; Sequence=VSP_041871, VSP_007059;
CC   -!- TISSUE SPECIFICITY: Expressed in the brain, isoform 2 is more abundant
CC       than isoform 1. Isoform 3 is ubiquitously expressed. Isoform 1 is most
CC       abundant in the skeletal muscle. Isoform 4 is ubiquitously expressed
CC       with relative high levels in brain, skeletal muscle, pancreas and
CC       testis. {ECO:0000269|PubMed:15469942}.
CC   -!- INDUCTION: Activated after Ras induction via a mechanism involving
CC       reactive oxygen species. {ECO:0000269|PubMed:16337592}.
CC   -!- PTM: Autophosphorylated.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB041926; BAA94838.1; -; mRNA.
DR   EMBL; AB035698; BAA90753.1; -; mRNA.
DR   EMBL; AY775058; AAV41830.1; -; mRNA.
DR   EMBL; AC233723; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471108; EAW90401.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90403.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90399.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90400.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90402.1; -; Genomic_DNA.
DR   EMBL; BC034673; AAH34673.1; -; mRNA.
DR   CCDS; CCDS45588.1; -. [Q8N4C8-1]
DR   CCDS; CCDS45589.1; -. [Q8N4C8-3]
DR   CCDS; CCDS45590.1; -. [Q8N4C8-4]
DR   RefSeq; NP_001020108.1; NM_001024937.3. [Q8N4C8-4]
DR   RefSeq; NP_001308165.1; NM_001321236.1.
DR   RefSeq; NP_056531.1; NM_015716.4. [Q8N4C8-2]
DR   RefSeq; NP_722549.2; NM_153827.4. [Q8N4C8-1]
DR   RefSeq; NP_733763.1; NM_170663.4. [Q8N4C8-3]
DR   AlphaFoldDB; Q8N4C8; -.
DR   SMR; Q8N4C8; -.
DR   BioGRID; 119075; 133.
DR   IntAct; Q8N4C8; 60.
DR   MINT; Q8N4C8; -.
DR   STRING; 9606.ENSP00000347427; -.
DR   BindingDB; Q8N4C8; -.
DR   ChEMBL; CHEMBL5518; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q8N4C8; -.
DR   GuidetoPHARMACOLOGY; 2103; -.
DR   GlyGen; Q8N4C8; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q8N4C8; -.
DR   PhosphoSitePlus; Q8N4C8; -.
DR   BioMuta; MINK1; -.
DR   DMDM; 296437370; -.
DR   EPD; Q8N4C8; -.
DR   jPOST; Q8N4C8; -.
DR   MassIVE; Q8N4C8; -.
DR   MaxQB; Q8N4C8; -.
DR   PaxDb; Q8N4C8; -.
DR   PeptideAtlas; Q8N4C8; -.
DR   PRIDE; Q8N4C8; -.
DR   ProteomicsDB; 71917; -. [Q8N4C8-1]
DR   ProteomicsDB; 71918; -. [Q8N4C8-2]
DR   ProteomicsDB; 71919; -. [Q8N4C8-3]
DR   ProteomicsDB; 71920; -. [Q8N4C8-4]
DR   ProteomicsDB; 71921; -. [Q8N4C8-5]
DR   Antibodypedia; 5678; 239 antibodies from 31 providers.
DR   DNASU; 50488; -.
DR   Ensembl; ENST00000347992.11; ENSP00000269296.7; ENSG00000141503.17. [Q8N4C8-3]
DR   Ensembl; ENST00000355280.11; ENSP00000347427.6; ENSG00000141503.17. [Q8N4C8-1]
DR   Ensembl; ENST00000453408.7; ENSP00000406487.3; ENSG00000141503.17. [Q8N4C8-4]
DR   GeneID; 50488; -.
DR   KEGG; hsa:50488; -.
DR   MANE-Select; ENST00000355280.11; ENSP00000347427.6; NM_153827.5; NP_722549.2.
DR   UCSC; uc010vsl.3; human. [Q8N4C8-1]
DR   CTD; 50488; -.
DR   DisGeNET; 50488; -.
DR   GeneCards; MINK1; -.
DR   HGNC; HGNC:17565; MINK1.
DR   HPA; ENSG00000141503; Low tissue specificity.
DR   MIM; 609426; gene.
DR   neXtProt; NX_Q8N4C8; -.
DR   OpenTargets; ENSG00000141503; -.
DR   PharmGKB; PA134910641; -.
DR   VEuPathDB; HostDB:ENSG00000141503; -.
DR   eggNOG; KOG0587; Eukaryota.
DR   GeneTree; ENSGT00950000183196; -.
DR   InParanoid; Q8N4C8; -.
DR   OMA; WAQEYKR; -.
DR   OrthoDB; 669799at2759; -.
DR   PhylomeDB; Q8N4C8; -.
DR   TreeFam; TF105138; -.
DR   PathwayCommons; Q8N4C8; -.
DR   Reactome; R-HSA-2559580; Oxidative Stress Induced Senescence.
DR   SignaLink; Q8N4C8; -.
DR   SIGNOR; Q8N4C8; -.
DR   BioGRID-ORCS; 50488; 15 hits in 1112 CRISPR screens.
DR   ChiTaRS; MINK1; human.
DR   GeneWiki; MINK1; -.
DR   GenomeRNAi; 50488; -.
DR   Pharos; Q8N4C8; Tchem.
DR   PRO; PR:Q8N4C8; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q8N4C8; protein.
DR   Bgee; ENSG00000141503; Expressed in CA1 field of hippocampus and 206 other tissues.
DR   ExpressionAtlas; Q8N4C8; baseline and differential.
DR   Genevisible; Q8N4C8; HS.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0030424; C:axon; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0014069; C:postsynaptic density; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB.
DR   GO; GO:0007420; P:brain development; ISS:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISS:UniProtKB.
DR   GO; GO:0048813; P:dendrite morphogenesis; ISS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0007254; P:JNK cascade; TAS:ProtInc.
DR   GO; GO:0000165; P:MAPK cascade; IBA:GO_Central.
DR   GO; GO:0048812; P:neuron projection morphogenesis; IBA:GO_Central.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IMP:UniProtKB.
DR   GO; GO:1900745; P:positive regulation of p38MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IMP:CACAO.
DR   GO; GO:2000311; P:regulation of AMPA receptor activity; ISS:UniProtKB.
DR   GO; GO:0030334; P:regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0022407; P:regulation of cell-cell adhesion; IMP:UniProtKB.
DR   GO; GO:0001952; P:regulation of cell-matrix adhesion; IMP:UniProtKB.
DR   GO; GO:0043408; P:regulation of MAPK cascade; IBA:GO_Central.
DR   InterPro; IPR001180; CNH_dom.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00780; CNH; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00036; CNH; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50219; CNH; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell projection; Cytoplasm;
KW   Golgi apparatus; Kinase; Methylation; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Synapse; Transferase.
FT   CHAIN           1..1332
FT                   /note="Misshapen-like kinase 1"
FT                   /id="PRO_0000086329"
FT   DOMAIN          25..289
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          1019..1306
FT                   /note="CNH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00795"
FT   REGION          300..347
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          363..383
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          395..887
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          866..1332
FT                   /note="Mediates interaction with RAP2A"
FT                   /evidence="ECO:0000269|PubMed:18930710"
FT   REGION          902..943
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        300..320
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        321..335
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        363..381
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        395..467
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        468..498
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        543..573
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        647..662
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        667..687
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        715..732
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        766..780
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        786..825
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        828..843
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        902..934
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        153
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         31..39
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         54
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         324
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JM52"
FT   MOD_RES         326
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JM52"
FT   MOD_RES         501
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JM52"
FT   MOD_RES         509
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   MOD_RES         641
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         701
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         754
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         763
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18088087, ECO:0007744|PubMed:18220336,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:18691976,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         777
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         778
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:23186163"
FT   MOD_RES         782
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:18691976"
FT   MOD_RES         891
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JM52"
FT   VAR_SEQ         581..600
FT                   /note="Missing (in isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15469942"
FT                   /id="VSP_041871"
FT   VAR_SEQ         696..732
FT                   /note="Missing (in isoform 1, isoform 2 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:10708748"
FT                   /id="VSP_007059"
FT   VAR_SEQ         800
FT                   /note="A -> ASYKRAIGE (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10708748"
FT                   /id="VSP_007060"
FT   VARIANT         514
FT                   /note="A -> T (in dbSNP:rs56131206)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040799"
FT   VARIANT         771
FT                   /note="V -> A (in dbSNP:rs11556634)"
FT                   /evidence="ECO:0000269|PubMed:15469942,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_046058"
FT   VARIANT         775
FT                   /note="P -> L (in dbSNP:rs11556635)"
FT                   /evidence="ECO:0000269|PubMed:15469942,
FT                   ECO:0000269|PubMed:15489334, ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:19413330, ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT                   /id="VAR_046059"
FT   VARIANT         863
FT                   /note="V -> I (in dbSNP:rs2302319)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_046060"
FT   VARIANT         1010
FT                   /note="E -> V (in a gastric adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_046061"
FT   VARIANT         1200
FT                   /note="I -> V"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_040800"
SQ   SEQUENCE   1332 AA;  149822 MW;  3E3B182CDDB3659C CRC64;
     MGDPAPARSL DDIDLSALRD PAGIFELVEV VGNGTYGQVY KGRHVKTGQL AAIKVMDVTE
     DEEEEIKQEI NMLKKYSHHR NIATYYGAFI KKSPPGNDDQ LWLVMEFCGA GSVTDLVKNT
     KGNALKEDCI AYICREILRG LAHLHAHKVI HRDIKGQNVL LTENAEVKLV DFGVSAQLDR
     TVGRRNTFIG TPYWMAPEVI ACDENPDATY DYRSDIWSLG ITAIEMAEGA PPLCDMHPMR
     ALFLIPRNPP PRLKSKKWSK KFIDFIDTCL IKTYLSRPPT EQLLKFPFIR DQPTERQVRI
     QLKDHIDRSR KKRGEKEETE YEYSGSEEED DSHGEEGEPS SIMNVPGEST LRREFLRLQQ
     ENKSNSEALK QQQQLQQQQQ RDPEAHIKHL LHQRQRRIEE QKEERRRVEE QQRREREQRK
     LQEKEQQRRL EDMQALRREE ERRQAEREQE YKRKQLEEQR QSERLQRQLQ QEHAYLKSLQ
     QQQQQQQLQK QQQQQLLPGD RKPLYHYGRG MNPADKPAWA REVEERTRMN KQQNSPLAKS
     KPGSTGPEPP IPQASPGPPG PLSQTPPMQR PVEPQEGPHK SLVAHRVPLK PYAAPVPRSQ
     SLQDQPTRNL AAFPASHDPD PAIPAPTATP SARGAVIRQN SDPTSEGPGP SPNPPAWVRP
     DNEAPPKVPQ RTSSIATALN TSGAGGSRPA QAVRARPRSN SAWQIYLQRR AERGTPKPPG
     PPAQPPGPPN ASSNPDLRRS DPGWERSDSV LPASHGHLPQ AGSLERNRVG VSSKPDSSPV
     LSPGNKAKPD DHRSRPGRPA DFVLLKERTL DEAPRPPKKA MDYSSSSEEV ESSEDDEEEG
     EGGPAEGSRD TPGGRSDGDT DSVSTMVVHD VEEITGTQPP YGGGTMVVQR TPEEERNLLH
     ADSNGYTNLP DVVQPSHSPT ENSKGQSPPS KDGSGDYQSR GLVKAPGKSS FTMFVDLGIY
     QPGGSGDSIP ITALVGGEGT RLDQLQYDVR KGSVVNVNPT NTRAHSETPE IRKYKKRFNS
     EILCAALWGV NLLVGTENGL MLLDRSGQGK VYGLIGRRRF QQMDVLEGLN LLITISGKRN
     KLRVYYLSWL RNKILHNDPE VEKKQGWTTV GDMEGCGHYR VVKYERIKFL VIALKSSVEV
     YAWAPKPYHK FMAFKSFADL PHRPLLVDLT VEEGQRLKVI YGSSAGFHAV DVDSGNSYDI
     YIPVHIQSQI TPHAIIFLPN TDGMEMLLCY EDEGVYVNTY GRIIKDVVLQ WGEMPTSVAY
     ICSNQIMGWG EKAIEIRSVE TGHLDGVFMH KRAQRLKFLC ERNDKVFFAS VRSGGSSQVY
     FMTLNRNCIM NW
//
